[Journal logo]

Volume 64 
Part 11 
Pages o2219-o2220  
November 2008  

Received 5 October 2008
Accepted 23 October 2008
Online 31 October 2008

Key indicators
Single-crystal X-ray study
T = 293 K
Mean [sigma](C-C) = 0.005 Å
R = 0.047
wR = 0.132
Data-to-parameter ratio = 8.1
Details
Open access

Ethyl 3-hydroxy-13-methyl-4'-phenyl-2'-(3,4,5-trimethoxyphenyl)-6,7,8,9,11,12,13,14,15,16-decahydrospiro[cyclopenta[a]phenanthrene-16,3'-pyrrolidine]-5'-carboxylate

aDepartment of Physics, Easwari Engineering College, Ramapuram, Chennai 600 089, India,bDepartment of Analytical Chemistry, University of Madras, Guindy Campus, Chennai 600025, India, and cDepartment of Physics, SRM University, Ramapuram Campus, Chennai 600 089, India
Correspondence e-mail: sudharose18@gmail.com

In the title compound, C39H45NO7,the pyrrolidine ring is connected to an estrone group, a trimethoxy benzene and a phenyl ring. The pyrrolidine ring exhibits a twist conformation and the other five-membered ring an envelope conformation. Molecules are linked by N-H...O hydrogen bonds, C-H...[pi] interactions and C-H...O hydrogen bonds.

Related literature

For general background, see: García-Peláez et al. (2004[García-Peláez, B., Ferrer-Lorente, R., Gómez-Ollés, S., Fernández-López, J. A., Remesar, X. & Alemany, M. (2004). J. Dairy Sci. 87, 2331-2336.]); Holland and Roy (1995[Holland, M. B. & Roy, D. (1995). Carcinogenesis, 16, 1955-1961.]); Obniska et al. (2002[Obniska, J., Zeic, A. & Zagorska, A. (2002). Acta Pol. Pharm. 59, 209-213.]); Suzuki et al. (1994[Suzuki, T., Nagasu Kawai, H., Fujiwara, K. & Tsuji, T. (1994). Tetrahedron Lett, 44, 6095-6098.]). For bond-length data, see: Allen et al. (1987[Allen, F. H., Kennard, O., Watson, D. G., Brammer, L., Orpen, A. G. & Taylor, R. (1987). J. Chem. Soc. Perkin Trans. 2, pp. S1-19.]). For puckering parameters, see: Cremer & Pople (1975[Cremer, D. & Pople, J. A. (1975). J. Am. Chem. Soc. 97, 1354-1358.]). For asymmetry parameters, see: Nardelli (1983[Nardelli, M. (1983). Acta Cryst. C39, 1141-1142.]).

[Scheme 1]

Experimental

Crystal data
  • C39H45NO7

  • Mr = 639.76

  • Monoclinic, C 2

  • a = 26.1776 (6) Å

  • b = 10.3379 (2) Å

  • c = 13.6631 (3) Å

  • [beta] = 91.1250 (10)°

  • V = 3696.82 (14) Å3

  • Z = 4

  • Mo K[alpha] radiation

  • [mu] = 0.08 mm-1

  • T = 293 (2) K

  • 0.30 × 0.30 × 0.25 mm

Data collection
  • Bruker Kappa APEXII diffractometer

  • Absorption correction: multi-scan (Blessing, 1995[Blessing, R. H. (1995). Acta Cryst. A51, 33-38.]) Tmin = 0.977, Tmax = 0.981

  • 38566 measured reflections

  • 3462 independent reflections

  • 3186 reflections with I > 2[sigma](I)

  • Rint = 0.027

Refinement
  • R[F2 > 2[sigma](F2)] = 0.047

  • wR(F2) = 0.132

  • S = 1.11

  • 3462 reflections

  • 425 parameters

  • 319 restraints

  • H-atom parameters constrained

  • [Delta][rho]max = 0.48 e Å-3

  • [Delta][rho]min = -0.24 e Å-3

Table 1
Hydrogen-bond geometry (Å, °)

D-H...A D-H H...A D...A D-H...A
O2-H2A...N1i 0.82 1.99 2.782 (4) 163
C39-H39A...O3ii 0.96 2.56 3.378 (4) 144
C29-H29A...Cg1iii 0.96 3.00 3.820 (4) 144
Symmetry codes: (i) [x+{\script{1\over 2}}, y-{\script{1\over 2}}, z]; (ii) [-x+{\script{1\over 2}}, y-{\script{1\over 2}}, -z+2]; (iii) [-x+{\script{1\over 2}}, y+{\script{1\over 2}}, -z+1].

Data collection: APEX2 (Bruker, 2004[Bruker (2004). SMART, SAINT and XPREP. Bruker AXS Inc., Madison,Wisconsin, USA.]); cell refinement: APEX2 and SAINT (Bruker, 2004[Bruker (2004). SMART, SAINT and XPREP. Bruker AXS Inc., Madison,Wisconsin, USA.]); data reduction: SAINT and XPREP Bruker, 2004[Bruker (2004). SMART, SAINT and XPREP. Bruker AXS Inc., Madison,Wisconsin, USA.]); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); molecular graphics: ORTEP-3 (Farrugia, 1997[Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565.]); software used to prepare material for publication: PLATON (Spek, 2003[Spek, A. L. (2003). J. Appl. Cryst. 36, 7-13.]).


Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: BT2805 ).


Acknowledgements

ETSK thanks Professor M. N. Ponnuswamy and Professor D. Velmurugan, Department of Crystallography and Biophysics, University of Madras, India, for their guidance and valuable suggestions. ETSK also thanks SRM Management for their support.

References

Allen, F. H., Kennard, O., Watson, D. G., Brammer, L., Orpen, A. G. & Taylor, R. (1987). J. Chem. Soc. Perkin Trans. 2, pp. S1-19.
Blessing, R. H. (1995). Acta Cryst. A51, 33-38.  [CrossRef] [details]
Bruker (2004). SMART, SAINT and XPREP. Bruker AXS Inc., Madison,Wisconsin, USA.
Cremer, D. & Pople, J. A. (1975). J. Am. Chem. Soc. 97, 1354-1358.  [CrossRef] [ChemPort] [ISI]
Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565.  [CrossRef] [details]
García-Peláez, B., Ferrer-Lorente, R., Gómez-Ollés, S., Fernández-López, J. A., Remesar, X. & Alemany, M. (2004). J. Dairy Sci. 87, 2331-2336.  [PubMed]
Holland, M. B. & Roy, D. (1995). Carcinogenesis, 16, 1955-1961.  [CrossRef] [ChemPort] [PubMed]
Nardelli, M. (1983). Acta Cryst. C39, 1141-1142.  [CrossRef] [details]
Obniska, J., Zeic, A. & Zagorska, A. (2002). Acta Pol. Pharm. 59, 209-213.  [PubMed] [ChemPort]
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.  [CrossRef] [details]
Spek, A. L. (2003). J. Appl. Cryst. 36, 7-13.  [ISI] [CrossRef] [ChemPort] [details]
Suzuki, T., Nagasu Kawai, H., Fujiwara, K. & Tsuji, T. (1994). Tetrahedron Lett, 44, 6095-6098.  [CrossRef]


Acta Cryst (2008). E64, o2219-o2220   [ doi:10.1107/S1600536808034582 ]

This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.